Search

Government agencies can use artificial intelligence to make better decisions and be more efficient while using Abt’s tools to mitigate risk.

Abt Global’s proven health systems solutions — spanning financing, efficiency, resilience, private sector engagement, and digital integration — equip partner governments to sustain health gains and transition donor-funded programs to full country ownership.

Abt builds evidence and identifies promising practices to help workers find and retain jobs and advance to higher-paying positions. Our experts provide technical assistance to partners such as U.S. federal, state, and local government workforce agencies; education institutions; and community and philanthropic organizations. Our strategies include a wide range of research-informed approaches generating actionable evidence to improve economic well-being. To promote fairness, our approaches address the needs of certain populations, such as healthcare workers and those with disabilities, substance use disorders, and justice system involvement.

Two reports provide insight on ways state housing finance agencies can advance affordable housing through energy efficiency efforts.

Abt Global was subcontracted by RMC Research to help the National Institute for Literacy promote the findings and recommendations of the National Early Literacy Panel. The Panel synthesized research on the teaching of literacy and literacy-related skills…

The Agency for Healthcare Research and Quality’s (AHRQ) Making Health Care Safer (MHCS) reports have had an important role in reducing harm and improving the safety and quality of care for patients. 

Rhode Island’s Preschool Development Grant – Birth through Age Five (PDG) grant is being used to implement a plan to ensure all children from birth through age 5 (B-5) are supported by services and programs that will prepare them for lifelong success. To…

From the start of the COVID-19 pandemic, CDC needed timely information on COVID-19 illness characterization and vaccine effectiveness in this highly exposed cohort. CDC also needed data on rates of symptomatic and asymptomatic infection and re-infection…